Oxford University UK Halts Hydroxychloroquine Trial, Calling It is 'Ineffective' for Covid-19 Sufferers

Oxford University

Oxford University

UK Halts Hydroxychloroquine Trial, Calling It ‘Ineffective’ for Covid-19 Sufferers (reuters.com)

Posted
by

EditorDavid

on Saturday June 06, 2020 @10: 34AM

from the factual-asserting-no dept.

An anonymous reader quotes Reuters:

British scientists halted a vital drug trial on Friday after it found out that the anti-malarial hydroxychloroquine, touted by U.S. President Donald Trump as a possible “game changer” within the pandemic, used to be “ineffective” at treating COVID-19 patients. “That just isn’t a therapy for COVID-19. It would not work,” Martin Landray, an Oxford University professor who’s co-leading the RECOVERY trial, urged reporters.

“This end result must quiet trade medical notice worldwide. We can now pause the use of a drug that is ineffective…”

Landray, a professor of medication and epidemiology at Oxford University, famed the “enormous speculation” about the drug as a therapy for COVID-19 however said there had been unless now “an absence of reputable recordsdata from big randomised trials”. He said the preliminary results from RECOVERY, which used to be a randomised trial, were now pretty certain: hydroxychloroquine doesn’t minimize the risk of death among hospitalised patients with COVID-19.

“If which that you just can well perhaps be admitted to health facility, compose not seize hydroxychloroquine,” he said.

The trial lively over 11,000 patients in a randomized trial begun in March.

The article ends by quoting Parastou Donyai, director of Pharmacy Apply on the University of Studying in England, who describes the announcement as “welcome relief to thousands of scientists, medical doctors and lecturers who were crying out for proper proof of whether or not hydroxychloroquine works in COVID-19 or not” — and calling the conclusion that it doesn’t work “definitive.”